Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is
increasing in prevalence. HF health expenditures are considerable and will increase …

Background Our previous review reported great variability in the incidence and prevalence
of atrial fibrillation (AF) in non-Western cohorts, especially from Asian countries; in recent …

Background Most data on mortality and prognostic factors in patients with heart failure come
from North America and Europe, with little information from other regions. Here, in the …

Abstract The Eastern Mediterranean region (EMR) comprises 22 countries or territories
spanning from Morocco in the west to Pakistan in the east, and contains a population of …

Background There are few data on heart failure (HF) patients from Africa, Asia, the Middle
East and South America. Methods INTER-CHF is a prospective study that enrolled HF …

While the interplay between heart failure (HF) and atrial fibrillation (AF) has been extensively
studied, little is known regarding HF and atrial flutter (AFL), which may be managed …

Aims Acute heart failure (AHF) leads to a drastic increase in mortality and rehospitalization.
The aim of the study was to identify prognostic variables in a real‐life population of AHF …

For many years, data about heart failure (HF) was only limited to Western countries but in the
last few years, well designed heart failure registries have been conducted in many …

Background Heart failure (HF) is an emerging epidemic in China and accounts for significant
healthcare resource utilization in the inpatient setting. To create evidence‐based, life …

Aims Heart failure (HF) is a chronic and progressive syndrome associated with a poor
prognosis. While it may seem intuitive that the risk of adverse outcomes varies across the …